Biliary tract cancer and pancreatic cancer
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Performance Status 0-1 Patients over 20 years of age to 80 years Patients with Pancreas or biliary tract cancer without multiple organ failure. Patients with serum total bilirubin levels greater than 3.0mg/dl.
Exclusion criteria
Exclusion criteria: Patients who do not agree with this study. Patients with cirrhosis or active hepatitis. Patients with severe cardiac or respiratory disease. Patients who receive hemodialysis. Patients with pregnant. Patients with cancer in other organs. Patients who were deemed inappropriate by the attending physician.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of postoperative infectious complications | — |
Secondary
| Measure | Time frame |
|---|---|
| Cellular immunity and intestinal integrity( Concanavalin A, Phytohemagglutin, Diamine oxydase activity) | — |
Countries
Japan
Contacts
Kobe university hospital Hepato biliary pancreatic surgery